136 related articles for article (PubMed ID: 197752)
1. [Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin].
Petrov RV; Shemanova GF; Panteleev EI; Dmitrieva LN; Vlasova EV
Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):71-4. PubMed ID: 197752
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
[TBL] [Abstract][Full Text] [Related]
3. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
[TBL] [Abstract][Full Text] [Related]
4. [Homogeneous Cl. perfringens alpha-anatoxin: its physicochemical and immunogenic properties].
Shemanova GF; Petrov RV; Dmitrieva LN; Panteleev EI; Drachev VA
Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):117-22. PubMed ID: 208330
[TBL] [Abstract][Full Text] [Related]
5. Alpha toxoid of Clostridium perfringens. II. Immunogenicity of the toxoid.
Ito A
Jpn J Med Sci Biol; 1970 Feb; 23(1):21-30. PubMed ID: 4317538
[No Abstract] [Full Text] [Related]
6. [Study of the interrelationship between the content of immunizing units and the immunogenicity of C1. perfringens anatoxins].
Nenashev VP; Akhundova KA
Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):93-6. PubMed ID: 173119
[TBL] [Abstract][Full Text] [Related]
7. [Use of the passive hemagglutination test for the purpose of determining antibody levels following animal immunization with Cl. perfringens toxoid].
Shemanova GF; Dmitrieva LN; Vlasova EV; Panteleev EI; Moshiashvili IIa
Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):85-8. PubMed ID: 193324
[TBL] [Abstract][Full Text] [Related]
8. [Immunogenic properties of Clostridium perfringens type A anatheta-hemolysin].
Sergeeva TI; Dolgikh MS; Blagoveshchenskiĭ VA
Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):71-5. PubMed ID: 6275640
[TBL] [Abstract][Full Text] [Related]
9. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
[TBL] [Abstract][Full Text] [Related]
10. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
Silva ROS; Duarte MC; Oliveira Junior CA; de Assis RA; Lana AMQ; Lobato FCF
Anaerobe; 2018 Dec; 54():19-22. PubMed ID: 30076896
[TBL] [Abstract][Full Text] [Related]
11. [Protective properties of theta-hemolysin obtained by affinity chromatography].
Efimova MG; Blagoveshchenskiĭ VA; Khatuntseva BV
Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):87-92. PubMed ID: 6297191
[TBL] [Abstract][Full Text] [Related]
12. [Sensitizing properties of purified concentrated Cl. perfringens toxoids].
Kalinichenko NF; Starobinets ZG; Podgornaia LG; Biriukova SV
Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):113-5. PubMed ID: 4330843
[No Abstract] [Full Text] [Related]
13. [Immune response of mice of different inbred lines to Clostridium oedematiens anatoxin].
Petrov RV; Panteleev EI; Moshiashvili IIa; Shemanova GF; Vlasova EV
Biull Eksp Biol Med; 1977 Feb; 83(2):198-200. PubMed ID: 558013
[TBL] [Abstract][Full Text] [Related]
14. [Immunization against gas gangrene and tetanus with sexta-anatoxin (in experiments with animals)].
Vlasova EV; Larina IA
Zh Mikrobiol Epidemiol Immunobiol; 1969 Jul; 46(7):113-6. PubMed ID: 4315881
[No Abstract] [Full Text] [Related]
15. [Preparation and evaluation of immunogenic properties of Clostridium perfringens type A toxoid].
Rymkiewicz D; Sawicki J; Brühl A; Sochańska R
Med Dosw Mikrobiol; 1979; 31(2):95-102. PubMed ID: 228130
[No Abstract] [Full Text] [Related]
16. Anti-idiotypic antibody-induced protection against Clostridium perfringens type D.
Percival DA; Shuttleworth AD; Williamson ED; Kelly DC
Infect Immun; 1990 Aug; 58(8):2487-92. PubMed ID: 1695203
[TBL] [Abstract][Full Text] [Related]
17. [The functional activity of wound mononuclear phagocytosing cells in revaccination with a Clostridium perfringens anatoxin].
Sergeeva TI; Zaĭtseva LG; Chirikova EV; Vasil'eva EI; Babaĭtseva VA; Kornienko OIu
Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):63-5. PubMed ID: 7879544
[No Abstract] [Full Text] [Related]
18. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A.
Shemanova GF; Vlasova EV; Sergeeva TI; Panteleyev EI
Arch Roum Pathol Exp Microbiol; 1981; 40(4):299-303. PubMed ID: 6280638
[No Abstract] [Full Text] [Related]
19. [Properties of C1. perfringens toxoids obtained from purified toxins].
Dmitrieva LN; Shemanova GF; Vlasova EV; Akhundova KA
Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):110-4. PubMed ID: 868405
[TBL] [Abstract][Full Text] [Related]
20. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
Sonnenschein B
Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
